The New Jersey Supreme Court has ordered consolidation of more than 350 suits over alleged side effects from breast cancer drug Taxotere.

The court designated all cases involving allegations of hair loss from Taxotere as multicounty litigation, and assigned the group to Superior Court Judge James Hyland in Middlesex County for centralized case management. Chief Justice Stuart Rabner approved the application on Aug. 17.